Scott Birnbaum

Scott Birnbaum has a diverse work experience in the field of clinical operations and research. Scott is currently working at Intercept Pharmaceuticals as the Director of Clinical Operations since February 2022. Prior to this, they were the Associate Director of Clinical Operations at the same company from November 2019 to February 2022.

Before joining Intercept Pharmaceuticals, Scott worked at Celtaxsys, Inc. as the Director of Clinical Operations from January 2017 to November 2019. Scott also has experience as a Global Clinical Trial Manager at DOCS from April 2016 to December 2016.

Their previous roles include Clinical Project Manager at Sebacia from July 2015 to March 2016, Project Manager/Lead Clinical Research Associate at ProTrials Research from October 2006 to July 2015, and Senior Clinical Research Associate at Paragon Biomedical from October 2003 to September 2006.

Scott started their career at C&R Research Associates, Inc. as a Clinical Research Associate I from May 1999 to September 2003.

Scott Birnbaum attended Pope High School but it is unknown when they started or ended their education there. Scott then went on to attend American University from 1995 to 1999, where they completed a Bachelor of Arts degree in Communications.